PlumX Metrics
Embed PlumX Metrics

Copper(II) ions-immobilized virus-like hollow covalent organic frameworks for highly efficient capture and sensitive analysis of amyloid beta-peptide 1–42 by MALDI-MS

Chinese Chemical Letters, ISSN: 1001-8417, Vol: 33, Issue: 12, Page: 5174-5179
2022
  • 23
    Citations
  • 0
    Usage
  • 6
    Captures
  • 1
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    23
    • Citation Indexes
      23
  • Captures
    6
  • Mentions
    1
    • News Mentions
      1
      • 1

Most Recent News

Researchers at Fuzhou University Release New Data on Biomarkers [Copper(Ii) Ions-immobilized Virus-like Hollow Covalent Organic Frameworks for Highly Efficient Capture and Sensitive Analysis of Amyloid Beta-peptide 1-42 By Maldi-ms]

2022 DEC 01 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Daily -- Fresh data on Diagnostics and Screening - Biomarkers

Article Description

Amyloid beta-peptide 1–42 (A β 1–42) is one of the biomarkers of Alzheimer's disease, and its selective capture and quantitative detection are important for diagnosis and treatment of Alzheimer's disease. Herein, copper(II) ions-immobilized virus-like hollow covalent organic frameworks (V-HCOFs@Cu 2+ ) were synthesized by a facile approach. The as-prepared V-HCOFs@Cu 2+ showed unique morphology, ultra-high specific surface (2552 m 2 /g), uniform mesoporous structure (3.2 nm), superior chemical stability and abundant binding sites. Based on these excellent properties, the V-HCOFs@Cu 2+ could be adopted as an ideal enrichment probe for highly efficient capture of A β 1–42, exhibiting high adsorption capacity (320 mg/g), and fast adsorption equilibration time (3 min). In addition, an attractive approach of the V-HCOFs@Cu 2+ -based matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) was developed for the rapid screening and quantitative analysis of A β 1–42 in human serum by using C-peptide as an internal standard, which exhibited low limit of detection (LOD, 0.2 fmol/µL), and satisfactory recovery. This work provides an alternative solution for enrichment of biomarkers and also offers the potential applications of COFs in clinical analysis

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know